The first partner company is on the path to market, but the implications are clear: eXoZymes has created a scalable production engine for molecules that were previously too rare or expensive to make.

The Tata Group and The New York Academy of Sciences gathered at the historic Taj Mahal Palace in Mumbai on Friday, December 5 ...

LOS ANGELES, CALIFORNIA / ACCESS Newswire / December 11, 2025 /Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of ...

Learn how the Chemical Industry is preparing for a sustainable future through green chemistry, circular economy practices, ...

For years, sugar substitutes like aspartame, sucralose, and sugar alcohols have been promoted as safer choices for people ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...

The costs of a hail damage have ballooned over the past two decades, prompting researchers to resort to extreme measures to ...

An Institute for Value-Based Medicine ® event held in New Haven, Connecticut, on October 30, 2025, brought together a diverse ...

Rocket Pharmaceuticals (NASDAQ:RCKT) advances gene-therapy innovation and appears in broader discussions involving the nasdaq ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...